Showing results (111-120 of 266) with videos related to
Sort By:
Pageof 27
Cancer|February 18, 2017
Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology GroupDavid O Walterhouse, Alberto S Pappo, Jane L Meza, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology GroupDavid O Walterhouse, Alberto S Pappo, Jane L Meza, et al.Pediatric Blood & Cancer|May 17, 2023
Feasibility of indocyanine green-guided localization of pulmonary nodules in children with solid tumorsAbdelhafeez H Abdelhafeez, Suraj Sarvode Mothi, Luca Pio, et al.JAMA Ophthalmology|December 27, 2019
Vascular Changes in the Retina and Choroid of Patients With EPAS1 Gain-of-Function Mutation SyndromePauline M Dmitriev, Herui Wang, Jared S Rosenblum, et al.Cancer|June 21, 2025
Acute cardiotoxicity in pediatric and adolescent patients with solid tumors treated with tyrosine kinase inhibitorsJessica Gartrell, Daniel A Mulrooney, Chia-Wei Hsu, et al.The Journal of Molecular Diagnostics : JMD|July 29, 2021
Assessment of BCOR Internal Tandem Duplications in Pediatric Cancers by Targeted RNA SequencingAlyaa Al-Ibraheemi, Juan Putra, Harrison K Tsai, et al.Pediatric Blood & Cancer|September 8, 2021
Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology GroupAnderson B Collier, Mark D Krailo, Ha M Dang, et al.Pediatric Blood & Cancer|March 28, 2009
Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinibKatherine A Janeway, Karen H Albritton, Annick D Van Den Abbeele, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2016
Prognostic Significance of Major Histocompatibility Complex Class II Expression in Pediatric Adrenocortical Tumors: A St. Jude and Children's Oncology Group StudyEmilia Modolo Pinto, Carlos Rodriguez-Galindo, John Kim Choi, et al.Pediatric Blood & Cancer|November 1, 2018
A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology GroupMichael S Isakoff, Robert Goldsby, Doojduen Villaluna, et al.Pageof 27